StonvexLoading…
StonvexStonvexStonvexCore line items from SW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $31.18B | $21.11B | $12.09B | $13.51B |
Operating Income | $1.72B | $1.01B | $1.37B | $1.56B |
Net Income | $699.00M | $319.00M | $825.00M | $1.03B |
EPS (Diluted) | $1.33 | $0.82 | $3.17 | $3.96 |
Total Assets | $45.16B | $43.76B | $14.05B | Not available |
Total Liabilities | $26.80B | $26.37B | $7.88B | Not available |
Cash & Equivalents | $892.00M | $855.00M | $1.00B | $841.00M |
Free Cash Flow OCF − CapEx | $1.20B | $17.00M | $630.00M | $503.00M |
Shares Outstanding | 522.31M | 520.44M | 260.35M | 261.00M |